ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

By: via Benzinga
Isis Pharmaceuticals (NASDAQ: ISIS) gained more than four percent in pre-market trading after information related to its pipeline ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.